150 related articles for article (PubMed ID: 6895119)
1. Response to pneumococcal vaccine among children with Hodgkin's disease.
Donaldson SS; Vosti KL; Berberich FR; Cox RS; Kaplan HS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S133-43. PubMed ID: 6895119
[TBL] [Abstract][Full Text] [Related]
2. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
Siber GR; Weitzman SA; Aisenberg AC
Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
[TBL] [Abstract][Full Text] [Related]
3. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
[TBL] [Abstract][Full Text] [Related]
4. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.
Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D
Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
Landesman SH; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
[TBL] [Abstract][Full Text] [Related]
6. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
[TBL] [Abstract][Full Text] [Related]
7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
8. Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae.
Giebink GS; Le CT; Cosio FG; Spika JS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S168-78. PubMed ID: 7025156
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease.
Frederiksen B; Specht L; Henrichsen J; Pedersen FK; Pedersen-Bjergaard J
Eur J Haematol; 1989 Jul; 43(1):45-9. PubMed ID: 2767242
[TBL] [Abstract][Full Text] [Related]
10. [DNA synthesis in PHA-stimulated lymphocyte cultures from Hodgkin's disease patients and their changes following splenectomy and the effect of chemotherapy treatment using the MOPP scheme].
Cadel Z
Nowotwory; 1981; 31(3-4):191-8. PubMed ID: 6896378
[No Abstract] [Full Text] [Related]
11. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.
Siber GR; Gorham C; Martin P; Corkery JC; Schiffman G
Ann Intern Med; 1986 Apr; 104(4):467-75. PubMed ID: 3082268
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children.
Pedersen FK; Henrichsen J; Schiffman G
Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661
[TBL] [Abstract][Full Text] [Related]
15. Summarized vs. type-specific analysis of antibody to pneumococcal capsular polysaccharides.
Giebink GS; Le CT; Spika JS
Rev Infect Dis; 1981; 3 Suppl():S43-50. PubMed ID: 7280448
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease.
Chan CY; Molrine DC; George S; Tarbell NJ; Mauch P; Diller L; Shamberger RC; Phillips NR; Goorin A; Ambrosino DM
J Infect Dis; 1996 Jan; 173(1):256-8. PubMed ID: 8537671
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.
Hilleman MR; Carlson AJ; McLean AA; Vella PP; Weibel RE; Woodhour AF
Rev Infect Dis; 1981; 3 Suppl():S31-42. PubMed ID: 7025159
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal vaccine failures. Two case reports and review.
Sumaya CV; Harbison RW; Britton HA
Am J Dis Child; 1981 Feb; 135(2):155-8. PubMed ID: 7468549
[TBL] [Abstract][Full Text] [Related]
19. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
20. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.
Giebink GS; Le CT; Schiffman G
J Pediatr; 1984 Oct; 105(4):576-82. PubMed ID: 6481533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
